Global Biotech Revolution is a youth-led nonprofit organisation focused on inspiring and developing the next generation of leaders in biotech and healthcare.

Global Biotech Revolution

Global Biotech Revolution | 7,760 followers on LinkedIn. Inspiring and Developing future leaders in biotech &amp; healthcare

Join us: https://shorturl.at/Gjh0M | Global Biotech Revolution (GBR) is a youth-led nonprofit which connects and develops future leaders to accelerate the growth and advancement of the global biotech ecosystem. The flagship event of GBR is the GapSummit, an annual student-run world-class biotechnology leadership summit with the core objectives of substantively discussing pressing challenges facing the bio-economy and catalysing innovation to solve these challenges. As the only intergenerational conference of its kind, the GapSummit competitively selects 100 Leaders of Tomorrow from around the world to attend, and recruits current leaders across the global biotech community to inspire the next generation.

Introspection Innovation Impact

Ipshita Mandal-Johnson

Biotech curious about Science and tech...//Knowledge manager-IP area at Ceibo

Verónica Delgado. PhD

VC | R&D in Pharma & Biotech | Startup Advisor

Andrei Afanasiev

Senior Health Copywriter • Digital Strategist • Biotechnologist

Guilherme Tonial

Calling all biotech enthusiasts - join us at GBR! We are a youth-led not-for-profit organisation that aims to inspire and develop the next generation of leaders to ensure the sustainability and growth of the biotechnology, healthcare and life sciences sector. What we’re looking for We are currently recruiting for a number of roles listed below, and we are searching for motivated and organized candidates who are passionate about GBR’s mission worldwide. As the applications will be reviewed on a rolling basis, we strongly recommend applying as soon as you are able to do so. If you applied in the past but have not heard from us - feel free to reapply. Check our website for more details: https://lnkd.in/eAAgu2Tn More about the roles here: https://lnkd.in/dJYJjuDk Apply here: https://lnkd.in/eNkYtKDp or scan the QR code at the end of the post! We are eager to welcome new members! #biotech #nonprofit #volunteering #leaders #future

Dr. Gustavo Riboldi brings extensive expertise to the entrepreneurship track as a judge. With solid scientific knowledge in drug development, he is deeply involved in bridging biotech innovation with venture capital funding. His work focuses on advancing early-stage ventures and fostering collaborations that drive transformative healthcare solutions. Dr. Riboldi’s commitment to the biotech sector extends to empowering innovators who are reshaping drug development and healthcare delivery. We are delighted to have him on the judging panel, where his insights and guidance will undoubtedly inspire participants to refine their ideas and accelerate the path to impactful innovations. #entrepreneurship #judge #biotech

We’re thrilled to welcome David Clark to the venture capital track judging panel as the competition enters its final stages. With over a decade of experience as an operator, David has built and scaled new ventures across startups, corporates, and government initiatives in Estonia and the UK. His leadership and hands-on approach have been pivotal in fostering innovation and driving impactful growth. Beyond his operational roles, David has mentored hundreds of startups through accelerators and hackathons, contributing to the success of the next generation of entrepreneurs. As a Supervisory Board member at TFTAK, Estonia’s leading Food & Fermentation laboratory, and Laser Diagnostic Instruments, a cleantech innovator, David continues to champion breakthroughs in biotech and sustainability. We are excited to see his insights shape the trajectory of this year’s competition! https://www.tera.vc/ #vc #competition #biotech #judge

As the VoT approaches its grand finale, we are honored to welcome Dr David Carr to the consulting track judging panel. With extensive expertise in pricing and market access, David has guided pharmaceutical and biotech clients through complex strategic decisions. From asset opportunity assessments to evidence generation planning, his analytical and innovative thinking is a cornerstone of his work. As a leader, David has also contributed to industry conversations on transformative topics, including cell and gene therapies, digital therapeutics, and evolving trends in pricing strategy. His depth of knowledge and commitment to advancing the life sciences industry make him an invaluable addition to the judging panel, and we are excited for the insights he will bring to this year’s competition. https://lnkd.in/e3VpgdKE #biotech #competition #judge

We are pleased to introduce Eugenio Cantuarias to the consulting track as we approach the competition finale. Eugenio, Managing Partner at AceleraLatam , has over 15 years of experience in international business advisory and venture capital. His work with AceleraLatam involves mentoring early-stage Latin American startups, using a unique combination of business development and capital investment strategies. This approach empowers startups to drive sustainable growth and expand into new markets, making him a remarkable asset for our judging panel. In addition to his entrepreneurial ventures, Eugenio has collaborated with Frisson Capital and Add Ventures, showcasing his deep commitment to supporting innovative business models and fostering success across diverse sectors. His comprehensive understanding of the challenges and opportunities for startups in Latin America will greatly benefit participants in the consulting track, especially those aiming to make a global impact. #biotech #judge #venturecapital

We are thrilled to welcome June Angelides, MBE , to the venture capital judging panel! A Venture Partner at Samos Investments ( https://samos.vc/ ), June is celebrated for her role in backing and mentoring high-impact early-stage companies. Her investments at Samos, which include companies such as Charlotte Tilbury and Bloom & Wild, reflect her commitment to nurturing groundbreaking ideas from inception. June’s extensive experience working with startups, coupled with her entrepreneurial spirit, positions her as an ideal judge for the venture capital track. Known for her support of diverse and innovative founders, June brings a unique perspective that will be invaluable as participants showcase their ventures. Her guidance will help contestants sharpen their business strategies and refine their pitches, offering a lasting impact on their growth trajectories. #biotech #competition #judge

As we continue announcing our panel, we’re honored to have Samuel Edland on board as a judge for the consulting track. Sam is a Senior Manager in the Life Sciences Business Advisory practice at Wilson Sonsini https://lnkd.in/dsSPWNFU , where he specializes in advising early-stage life sciences companies. With an extensive background in corporate development, Sam has worked in both private and public biopharma, diagnostics, and healthcare enterprises, as well as with seed-stage venture capital funds. Sam’s track record includes roles at renowned companies such as Biogen and Foundation Medicine, in addition to his impactful contributions in corporate strategy. He has also consulted with the Ben Franklin Technology Partners fund. Sam’s dedication to empowering startups and driving innovation aligns perfectly with the goals of this competition, and we’re eager to see him support participants through his in-depth expertise. #competition #biotech #judge #wsgr

As we near the conclusion of our competition, we’re thrilled to have Seungho Lee join the judging panel for the venture capital track. A PhD candidate at UC Santa Cruz specializing in the epigenetics of stem cell pluripotency, Seungho combines deep academic knowledge with hands-on industry experience as a fellow at Vida Ventures. In his role, he assesses biotech investment opportunities, bringing a unique perspective that bridges scientific research and venture capital. With a background that includes healthcare investment banking at TD Cowen and business development at Horizon Therapeutics, Seungho is well-prepared to evaluate startups in the venture capital track. His journey from Northwestern University to biotech investment gives him a comprehensive understanding of the challenges and opportunities facing emerging biotech companies today, and we’re excited to have him offer his insights. #judge #competition #vot

As we approach the final stretch of the competition, we’re proud to showcase reflections from our participants on the journey so far. From hands-on experience in consulting strategies to tackling real-world case studies in pharma, they’re gaining insights into the industry’s most pressing challenges. Through international collaboration, expert-led webinars, and practical applications, participants are developing skills, expanding networks, and enhancing their understanding of the biotech landscape. These are the voices of tomorrow’s leaders—dedicated to reshaping the future of life sciences with each step! Our thanks to Christian Lehmann , Alisa K. , Carolina Aguila , Donald Heng Rong Ting, PhD & Keshav Todi ! #biotech #competition

msh id	COM:GLOBALBIOTECHREVOLUTION
symbol	-
name	Global Biotech Revolution
homepage url	https://globalbiotechrevolution.com
country	US
sector	Consumer Services
industry	Nonprofit / Education
market	PRIVATE
employee count	-
crunchbase url	https://www.crunchbase.com/organization/global-biotech-revolution
linkedin url	https://uk.linkedin.com/company/global-biotech-revolution
founders	-

market cap	-
enterprise value	-
stage	-
raised capital	-
valuation	-

monthly webtraffic	-
monthly webtraffic growth	-
growth score 14	-
growth score 28	-
growth score 90	-
growth score 365	-

revenue ltm	-
gross profit ltm	-
ebitda ltm	-
net income ltm	-
revenue ntm	-
gross profit ntm	-
ebitda ntm	-
net income ntm	-

growth cost and expenses	-
growth cost of revenue	-
growth depreciation and amortization	-
growth ebitda	-
growth ebitda ratio	-
growth eps	-
growth eps diluted	-
growth general and administrative expenses	-
growth gross profit	-
growth gross profit ratio	-

COM:GLOBALBIOTECHREVOLUTION

Global Biotech Revolution

Company Information

Market Metrics

Web & Growth Metrics

LTM & NTM Metrics

Growth & Performance Metrics

Operating Metrics

Balance Sheet Metrics

Financial Metrics (2022-2026)

cost and expenses	-
cost of revenue	-
depreciation and amortization	-
ebitda	-
ebitda ratio	-
eps	-
eps diluted	-
operating expenses	-
operating income	-
operating income ratio	-

accounts receivables	-
capital expenditure	-
cash at beginning of period	-
cash at end of period	-
inventory	-
working capital ttm	-

	2022	2023	2024	2025	2026
Revenue Metrics
Revenue	-	-	-	-	-
Revenue Growth	-	-	-	-	-
Revenue Multiple	-	-	-	-	-
Profit Metrics
Gross Profit	-	-	-	-	-
Gross Profit Growth	-	-	-	-	-
Gross Profit Multiple	-	-	-	-	-
EBITDA Metrics
EBITDA	-	-	-	-	-
EBITDA Growth	-	-	-	-	-
EBITDA Multiple	-	-	-	-	-
Net Income Metrics
Net Income	-	-	-	-	-
Net Income Growth	-	-	-	-	-
Net Income Multiple	-	-	-	-	-